Coll Crespo Blas's Form 4 filing
Structure Therapeutics Inc. (GPCR) · filed Sep 22, 2026
- Accession no.
- 0002037144-26-000004
- Filed
- Sep 22, 2026, 5:59 PM ET
- Trade date
- Sep 18-21, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 2 derivative transactions. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Coll Crespo BlasCIK 0002037144 | Officer (CHIEF MEDICAL OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 18, 2026 | Ordinary Shares | FTax withholdingDisposed | −10,626 | $11.67 | −$124,005.42 | 270,252 | Direct | |
| Sep 21, 2026 | Ordinary Shares | CConversionDisposed | −12,024 | $0.00 | $0 | 258,228 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 21, 2026 | Ordinary Shares | CConversionAcquired | +12,024 | $0.00 | $0 | 5,165 | Direct | |
| Sep 21, 2026 | Ordinary Shares | SSaleDisposed | −12,024 | $36.15 | −$434,618.3 | 1,157 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.